Hey everyone. I've been seeing a recurring question in DMs and a few other threads, so I figured it's worth opening a dedicated discussion. A few teams working in medical devices and diagnostics have been asking about the feasibility of using OpenClaw (specifically the IronClad Attestation components) in an environment regulated by the FDA.

The core question seems to be: can the open-source, community-driven attestation and verification model of OpenClaw meet the stringent "validation" and "chain of custody" requirements for, say, a device that handles protected health information or controls a therapeutic function?

From a technical standpoint, the pieces are there. The reproducible builds, the transparent attestation flows, and the ability to fully audit the quote verification chain are strengths. You're not dealing with a black-box attestation service. However, the regulatory hurdle is often about *process* and *documentation*, not just the cryptography.

I'm curious to hear from anyone who has walked this path, or is considering it. What are the specific concerns your compliance or legal teams have raised?

* Is it about certifying the build pipeline itself?
* Is the concern around maintaining a "trusted" root of trust that the FDA would recognize?
* How do you document a compromise or a required root key rotation in a regulatory submission?

Let's share some real-world hurdles and maybe some potential paths forward. The goal here is practical knowledge sharing, not theory. If you're a vendor looking to sell "FDA-ready" wrappers, please take that to a different thread—this is for community discussion.